Volker Knappertz insider trades: Aurinia Pharmaceuticals (AUPH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Volker reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | AUPH | ↓ Sell | 4,930 | $6.10 | $30K | Direct | Feb 29, 2024 (2d) |
| Feb 20, 2024 | AUPH | ↓ Sell | 25,146 | $5.48 | $138K | Direct | Feb 22, 2024 (2d) |
| Mar 26, 2021 | GWPH | ↓ Sell | 3,060 | $18.10 | $55K | Direct | Mar 30, 2021 (4d) |
| Jan 19, 2021 | GWPH | ↓ Sell | 6,000 | $11.67 | $70K | Direct | Jan 20, 2021 (1d) |
| Nov 24, 2020 | GWPH | ↓ Sell | 12,000 | $10.50 | $126K | Direct | Nov 25, 2020 (1d) |
| Nov 11, 2020 | GWPH | ↓ Sell | 6,000 | $10.00 | $60K | Direct | Nov 13, 2020 (2d) |
| Nov 4, 2020 | GWPH | ↓ Sell | 6,000 | $9.17 | $55K | Direct | Nov 5, 2020 (1d) |
| Aug 4, 2020 | GWPH | ↓ Sell | 6,000 | $11.11 | $67K | Direct | Aug 6, 2020 (2d) |
| Jul 20, 2020 | GWPH | ↓ Sell | 6,000 | $11.42 | $69K | Direct | Jul 22, 2020 (2d) |
| Jun 17, 2020 | GWPH | ↓ Sell | 22,296 | $11.17 | $249K | Direct | Jun 19, 2020 (2d) |
| Mar 2, 2020 | GWPH | ↓ Sell | 3,420 | $8.32 | $28K | Direct | Mar 4, 2020 (2d) |
| Feb 26, 2020 | GWPH | ↓ Sell | 3,012 | $9.18 | $28K | Direct | Feb 28, 2020 (2d) |
| May 20, 2019 | GWPH | ↓ Sell | 12,144 | $14.64 | $178K | Direct | May 21, 2019 (1d) |
| Mar 1, 2019 | GWPH | ↓ Sell | 3,732 | $14.46 | $54K | Direct | Mar 5, 2019 (4d) |
| Feb 26, 2019 | GWPH | ↓ Sell | 4,140 | $12.46 | $52K | Direct | Feb 28, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AUPH insiders
Open-market trades in the last 12 months
About Volker Knappertz's insider trades
Volker Knappertz is EVP, Research and Development at Aurinia Pharmaceuticals (AUPH). Since Feb 26, 2019, Volker has reported no open-market purchases and 15 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), option exercises (4 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AUPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.